Omada Health, Inc. (NASDAQ:OMDA) Stock Rated “Moderate Buy” by Wall Street Analysts

Posted by on Oct 2nd, 2026

Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the fourteen analysts that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $26.67.

Several research firms have recently commented on OMDA. BMO Capital Markets reiterated an “outperform” rating and issued a $24.00 price objective on shares of Omada Health in a report on Friday, August 7th. Weiss Ratings upgraded Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a report on Tuesday, August 11th. Canaccord Genuity Group raised their price target on Omada Health from $24.00 to $28.00 and gave the stock a “buy” rating in a research report on Tuesday, July 21st. BTIG Research reaffirmed a “buy” rating and issued a $35.00 price target on shares of Omada Health in a research note on Friday, September 11th. Finally, JPMorgan Chase & Co. boosted their price objective on Omada Health from $26.00 to $30.00 and gave the company an “overweight” rating in a research report on Friday, August 14th.

Get Our Latest Report on OMDA

Insider Buying and Selling

In related news, CFO Steven Cook sold 15,235 shares of the company’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $25.03, for a total transaction of $381,332.05. Following the completion of the sale, the chief financial officer directly owned 187,209 shares in the company, valued at $4,685,841.27. This represents a 7.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Sean Duffy sold 21,572 shares of the stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $23.62, for a total transaction of $509,530.64. Following the sale, the chief executive officer directly owned 411,861 shares of the company’s stock, valued at $9,728,156.82. The trade was a 4.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 122,721 shares of company stock valued at $2,843,167 over the last three months. 6.38% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. BlackRock Inc. bought a new stake in shares of Omada Health in the 2nd quarter worth approximately $48,775,000. Jefferies Financial Group Inc. bought a new position in shares of Omada Health during the second quarter valued at approximately $15,016,000. BIT Capital GmbH lifted its stake in Omada Health by 52.4% in the fourth quarter. BIT Capital GmbH now owns 940,238 shares of the company’s stock worth $14,837,000 after acquiring an additional 323,365 shares during the period. Madryn Asset Management LP purchased a new stake in Omada Health in the second quarter worth $12,814,410. Finally, Walleye Capital LLC bought a new stake in Omada Health in the second quarter valued at $11,648,000.

Omada Health Stock Performance

Shares of OMDA opened at $20.41 on Friday. Omada Health has a fifty-two week low of $10.28 and a fifty-two week high of $26.92. The firm has a 50 day moving average price of $21.80 and a 200-day moving average price of $18.64. The firm has a market cap of $1.25 billion, a price-to-earnings ratio of 408.20 and a beta of 2.04.

Omada Health (NASDAQ:OMDA – Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $0.08 EPS for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.10. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The company had revenue of $87.83 million for the quarter, compared to analysts’ expectations of $80.93 million. As a group, equities research analysts predict that Omada Health will post 0.09 earnings per share for the current year.

About Omada Health

(Get Free Report)

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines connected health devices, digital tools, health coaching and clinical support to help members improve their health and manage conditions such as diabetes, hypertension and musculoskeletal disorders.

The company’s services are designed for employers, health plans and other healthcare organizations seeking to support populations with ongoing healthcare needs.

Featured Stories

Analyst Recommendations for Omada Health (NASDAQ:OMDA)

Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.